Oilfield services are growing at almost 12% a year, and will push up to $291 billion by 2019, according to a new report.
Energy and Capital editor Keith Kohl reveals the secret behind some of the best profits inside the oil industry.
Chelsea Therapeutics just received FDA approval for its drug Northera. In no time flat, the company was snatched up by a bigger pharmaceutical company.
Energy and Capital editor Keith Kohl reports on the latest IPO by GasLog Partners, and questions whether investors will be rewarded in the short-term.
Over the past five years, emerging markets have done a whole lot of nothing. But the smart money is moving into them now...
Energy and Capital editor Keith Kohl reports on a small Texas town on the verge of banning hydraulic fracturing in the Barnett Shale.
With strong first quarter revenue and income growth, First Solar is expecting a big 2014.
It's billed as safe and clean, but that may not be enough to give a boost to hydro. This, despite a new DOE report which suggests we could easily double our hydro contributions.
Solar power's growing presence in the world is helping companies like Canadian Solar beat their own guidance.
SolarCity has a new collaboration. This time with HVAC company Carrier.
Energy and Capital editor Keith Kohl uncovers BP's new weapon to fight dwindling reserves.
Energy and Capital editor Keith Kohl takes a hard look at why South Texas is just one reason for investors to get their own piece of U.S. shale profits.
ENERGY AND CAPITAL
3 EAST READ ST
BALTIMORE, MD 21202
TEL: (877) 303-4529
FAX: (410) 814-5959
© ENERGY AND CAPITAL. ALL RIGHTS RESERVED.
